Literature DB >> 27260767

The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease.

David N O'Dwyer1, Robert P Dickson1, Bethany B Moore2.   

Abstract

The development of culture-independent techniques for microbiological analysis has uncovered the previously unappreciated complexity of the bacterial microbiome at various anatomic sites. The microbiome of the lung has relatively less bacterial biomass when compared with the lower gastrointestinal tract yet displays considerable diversity. The composition of the lung microbiome is determined by elimination, immigration, and relative growth within its communities. Chronic lung disease alters these factors. Many forms of chronic lung disease demonstrate exacerbations that drive disease progression and are poorly understood. Mounting evidence supports ways in which microbiota dysbiosis can influence host defense and immunity, and in turn may contribute to disease exacerbations. Thus, the key to understanding the pathogenesis of chronic lung disease may reside in deciphering the complex interactions between the host, pathogen, and resident microbiota during stable disease and exacerbations. In this brief review we discuss new insights into these labyrinthine relationships.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Year:  2016        PMID: 27260767      PMCID: PMC4894335          DOI: 10.4049/jimmunol.1600279

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  125 in total

1.  Airway impedance entropy and exacerbations in severe asthma.

Authors:  Sherif Gonem; Imraan Umar; Daniel Burke; Dhananjay Desai; Steven Corkill; John Owers-Bradley; Christopher E Brightling; Salman Siddiqui
Journal:  Eur Respir J       Date:  2012-03-09       Impact factor: 16.671

2.  Expression profiles of Toll-like receptors in non-small cell lung cancer and idiopathic pulmonary fibrosis.

Authors:  Katerina D Samara; Katerina M Antoniou; Konstantinos Karagiannis; Georgios Margaritopoulos; Ismini Lasithiotaki; Eleni Koutala; Nikolaos M Siafakas
Journal:  Int J Oncol       Date:  2012-02-15       Impact factor: 5.650

3.  Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation?

Authors:  Franziska A Stressmann; Geraint B Rogers; Peter Marsh; Andrew K Lilley; Thomas W V Daniels; Mary P Carroll; Lucas R Hoffman; Graeme Jones; Collette E Allen; Nilesh Patel; Benjamin Forbes; Andrew Tuck; Kenneth D Bruce
Journal:  J Cyst Fibros       Date:  2011-06-12       Impact factor: 5.482

4.  Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis.

Authors:  Aurélien Trompette; Eva S Gollwitzer; Koshika Yadava; Anke K Sichelstiel; Norbert Sprenger; Catherine Ngom-Bru; Carine Blanchard; Tobias Junt; Laurent P Nicod; Nicola L Harris; Benjamin J Marsland
Journal:  Nat Med       Date:  2014-01-05       Impact factor: 53.440

5.  Streptococcus pneumoniae triggers progression of pulmonary fibrosis through pneumolysin.

Authors:  Sarah Knippenberg; Bianca Ueberberg; Regina Maus; Jennifer Bohling; Nadine Ding; Meritxell Tort Tarres; Heinz-Gerd Hoymann; Danny Jonigk; Nicole Izykowski; James C Paton; Abiodun D Ogunniyi; Sandro Lindig; Michael Bauer; Tobias Welte; Werner Seeger; Andreas Guenther; Thomas H Sisson; Jack Gauldie; Martin Kolb; Ulrich A Maus
Journal:  Thorax       Date:  2015-05-11       Impact factor: 9.139

6.  Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns.

Authors:  Maria G Dominguez-Bello; Elizabeth K Costello; Monica Contreras; Magda Magris; Glida Hidalgo; Noah Fierer; Rob Knight
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

7.  Early respiratory microbiota composition determines bacterial succession patterns and respiratory health in children.

Authors:  Giske Biesbroek; Evgeni Tsivtsivadze; Elisabeth A M Sanders; Roy Montijn; Reinier H Veenhoven; Bart J F Keijser; Debby Bogaert
Journal:  Am J Respir Crit Care Med       Date:  2014-12-01       Impact factor: 21.405

8.  Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush.

Authors:  E Monsó; J Ruiz; A Rosell; J Manterola; J Fiz; J Morera; V Ausina
Journal:  Am J Respir Crit Care Med       Date:  1995-10       Impact factor: 21.405

9.  The Th17 pathway in cystic fibrosis lung disease.

Authors:  Hui-Leng Tan; Nicolas Regamey; Sarah Brown; Andrew Bush; Clare M Lloyd; Jane C Davies
Journal:  Am J Respir Crit Care Med       Date:  2011-04-07       Impact factor: 21.405

10.  Anti-Inflammatory Effects of Lactobacillus Rahmnosus and Bifidobacterium Breve on Cigarette Smoke Activated Human Macrophages.

Authors:  Esmaeil Mortaz; Ian M Adcock; Fabio L M Ricciardolo; Mohammad Varahram; Hamidreza Jamaati; Ali Akbar Velayati; Gert Folkerts; Johan Garssen
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

View more
  113 in total

1.  Overview and systematic review of studies of microbiome in schizophrenia and bipolar disorder.

Authors:  Tanya T Nguyen; Tomasz Kosciolek; Lisa T Eyler; Rob Knight; Dilip V Jeste
Journal:  J Psychiatr Res       Date:  2018-01-31       Impact factor: 4.791

2.  AB569, a nontoxic chemical tandem that kills major human pathogenic bacteria.

Authors:  Cameron T McDaniel; Warunya Panmanee; Geoffrey L Winsor; Erin Gill; Claire Bertelli; Michael J Schurr; Prateek Dongare; Andrew T Paul; Seung-Hyun B Ko; Gee W Lau; Nupur Dasgupta; Amy L Bogue; William E Miller; Joel E Mortensen; David B Haslam; Phillip Dexheimer; Daniel A Muruve; Bruce J Aronow; Malcolm D E Forbes; Marek Danilczuk; Fiona S L Brinkman; Robert E W Hancock; Thomas J Meyer; Daniel J Hassett
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-18       Impact factor: 11.205

Review 3.  The respiratory microbiome in idiopathic pulmonary fibrosis.

Authors:  Richard J Hewitt; Philip L Molyneaux
Journal:  Ann Transl Med       Date:  2017-06

Review 4.  Perspectives in lung microbiome research.

Authors:  Imran Sulaiman; Sheeja Schuster; Leopoldo N Segal
Journal:  Curr Opin Microbiol       Date:  2020-07-02       Impact factor: 7.934

Review 5.  The Human Microbiome and Understanding the 16S rRNA Gene in Translational Nursing Science.

Authors:  Nancy J Ames; Alexandra Ranucci; Brad Moriyama; Gwenyth R Wallen
Journal:  Nurs Res       Date:  2017 Mar/Apr       Impact factor: 2.381

Review 6.  Lung inflammation and disease: A perspective on microbial homeostasis and metabolism.

Authors:  Roberto Mendez; Sulagna Banerjee; Sanjoy K Bhattacharya; Santanu Banerjee
Journal:  IUBMB Life       Date:  2018-11-22       Impact factor: 3.885

7.  Differences in gut microbiome composition between persons with chronic schizophrenia and healthy comparison subjects.

Authors:  Tanya T Nguyen; Tomasz Kosciolek; Yadira Maldonado; Rebecca E Daly; Averria Sirkin Martin; Daniel McDonald; Rob Knight; Dilip V Jeste
Journal:  Schizophr Res       Date:  2018-09-26       Impact factor: 4.939

Review 8.  Evidence Supporting a Phased Immuno-physiological Approach to COVID-19 From Prevention Through Recovery.

Authors:  S F Yanuck; J Pizzorno; H Messier; K N Fitzgerald
Journal:  Integr Med (Encinitas)       Date:  2020

Review 9.  IL-17 in the lung: the good, the bad, and the ugly.

Authors:  Stephen J Gurczynski; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-31       Impact factor: 5.464

Review 10.  Probiotics, Photobiomodulation, and Disease Management: Controversies and Challenges.

Authors:  Laura Marinela Ailioaie; Gerhard Litscher
Journal:  Int J Mol Sci       Date:  2021-05-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.